Adapting Microarray Gene Expression Signatures for Early Melioidosis Diagnosis

Area of Science:

• Infectious Diseases
• Molecular Diagnostics
• Genomics

Background:

• Melioidosis, caused by Burkholderia pseudomallei, presents with nonspecific symptoms, leading to misdiagnosis and high mortality rates.
• Current diagnostic methods like bacterial culture are slow and have low sensitivity, delaying crucial treatment.
• Early and accurate laboratory diagnosis is essential for effective management of melioidosis.

Purpose of the Study:

• To develop a rapid diagnostic test for melioidosis using host gene expression signatures.
• To validate a real-time PCR assay targeting AIM2 and FAM26F genes for differentiating B. pseudomallei infections.

Main Methods:

• Adapted host gene expression signatures from microarray data of B. pseudomallei-infected cases.
• Developed a real-time PCR diagnostic test utilizing two differentially expressed genes: AIM2 and FAM26F.
• Tested blood samples from patients with confirmed melioidosis and other bacterial infections to validate the assay.

Main Results:

• The AIM2 and FAM26F expression algorithm demonstrated 82% sensitivity and 93% specificity in differentiating septicemic melioidosis from other sepsis cases.
• In nonbacteremic situations, the test showed 40% sensitivity and 54% specificity for identifying potential melioidosis cases.
• The developed PCR test provides results within 24 hours, significantly faster than traditional culture methods.

Conclusions:

• The combination algorithm using AIM2 and FAM26F gene expression offers a promising tool for early melioidosis diagnosis.
• This rapid molecular diagnostic approach can aid physicians in timely and specific treatment of B. pseudomallei infections.
• The test's speed and accuracy can potentially improve clinical outcomes and reduce mortality associated with melioidosis.